Table 2.
Concordance statistics of the matched prostate cancer and blood samples.
| Statistics | MAN2A1-FER | TRMT11-GRIK2 | mTOR-TP53BP1 | CCNH-c5orf30 | KDM4B-AC011523.2 | SLC45A2-AMACR | TMEM135-CCDC67 | LRRC59-FLJ60017 | Pten-NOLC1 |
|---|---|---|---|---|---|---|---|---|---|
| Prostate fusion sensitivity | 88% (22/25) | 28% (7/25) | 4% (1/25) | 36% (9/25) | 4% (1/25) | 80% (20/25) | 0% (0/25) | 8% (2/25) | 76% (19/25) |
| Blood fusion sensitivity | 68% (15/25) | 0% (0/25) | 100% (1/1) | 22.2% (2/9) | 0% (0/1) | 45% (9/20) | N/A | 0% (0/2) | 47.4% (9/19) |
| Blood fusion positive prediction value | 88.2% (15/17) | N/A | 50% (1/2) | 66.7% (2/3) | 0% (0/1) | 75% (9/12) | N/A | N/A | 90% (9/10) |